Hematology NewsExtended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Patient & Survivor CareCOVID-19 UpdatesLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantMultiple MyelomaMyelodysplastic Syndrome
Hematology NewsFive-minute SC injection of daratumumab in RRMMDecember 9, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsDurable responses with anti-BCMA CAR T-cell for multiple myelomaDecember 6, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsCOVID-19–related outcomes poor for patients with hematologic disease in ASH registryDecember 5, 2020COVID-19 UpdatesALLMultiple MyelomaB Cell LymphomaNon-Hodgkin Lymphoma
Circulating miRNA could be a potential biomarker for early diagnosis of MMNovember 24, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsHome care for bortezomib safe and reduces hospital visits in myeloma patientsNovember 11, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsSocioeconomic factors affect survival of multiple myeloma patientsOctober 22, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsOlder adults with multiple myeloma face heavy burden of careOctober 8, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsInitial response to novel agents preps MM patients for favorable transplant outcomesSeptember 24, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Oncology PracticeSurvey quantifies COVID-19’s impact on oncologySeptember 20, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaLung CancerLeukemia, Myelodysplasia, Transplantation
Hematology NewsStatins linked to improved survival in multiple myelomaSeptember 10, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsAge, other risk factors predict length of MM survivalAugust 27, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsElotuzumab-based therapy may benefit post-transplant response in multiple myelomaAugust 12, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA approves belantamab in relapsed/refractory multiple myelomaAugust 6, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsE.U. gives thumbs up for belantamab in R/R multiple myelomaJuly 28, 2020Multiple MyelomaMixed Topics
